Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Incidentie hepatitis C daalt na beschikbaar komen DAA’s
apr 2018 | Hepatitis